Companies / France
Drug Industry Damns Doctor Deal
April 2007 | Industry NewsThe French pharmaceutical industry has criticised a decision by national health insurer UNCAM to increase the fee for a doctor's consultation by EUR2 (US$2.71). As of 2008, general practitioners will earn EUR23 (US$31.16) for each consultation; however, drugmakers fear that the extra money will come out the drug budget. For example, as part of the deal UNCAM is encouraging greater generic substitution. In 2001, generics accounted for approximately 2.8% of the French drug market, yet by 2011
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
